0000950103-24-002452.txt : 20240220
0000950103-24-002452.hdr.sgml : 20240220
20240220175645
ACCESSION NUMBER: 0000950103-24-002452
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sabet-Peyman Afshin Justin
CENTRAL INDEX KEY: 0001956300
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39616
FILM NUMBER: 24655359
MAIL ADDRESS:
STREET 1: C/O PATIENT SQUARE EQUITY ADVISORS, LP
STREET 2: 2884 SAND HILL ROAD, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eargo, Inc.
CENTRAL INDEX KEY: 0001719395
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 273879804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2665 NORTH FIRST STREET
STREET 2: SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 650-351-7700
MAIL ADDRESS:
STREET 1: 2665 NORTH FIRST STREET
STREET 2: SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
dp206984_4-sabetpeyman.xml
FORM 4
X0508
4
2024-02-16
1
0001719395
Eargo, Inc.
EAR
0001956300
Sabet-Peyman Afshin Justin
C/O PATIENT SQUARE CAPITAL.
2884 SAND HILL ROAD, SUITE 100
MENLO PARK
CA
94025
1
0
0
0
0
Stock Options (Right to Buy)
2024-02-16
4
D
0
5859
D
2032-12-06
Common Stock
5859
0
D
Stock Options (Right to Buy)
2024-02-16
4
D
0
5000
D
2033-06-06
Common Stock
5000
0
D
Pursuant to the Agreement and Plan of Merger, dated October 29, 2023, by and among PSC Echo Parent LLC, PSC Echo Merger Sub Inc., and Eargo (the "Merger Agreement"), at the effective time of the merger (the "Effective Time"), each award of Eargo stock options ("Options") held by the reporting person and granted under the Eargo, Inc. 2020 Incentive Award Plan or the Eargo, Inc. 2010 Equity Incentive Plan that was outstanding and unexercised immediately prior to or upon the Effective Time, whether vested or unvested, was cancelled, with the holder of such Option becoming entitled to receive an amount in cash, without interest and subject to applicable tax withholding, equal to the product obtained by multiplying (i) the excess, if any, of the merger consideration of $2.55 per share in cash (the "Merger Consideration") over the per share exercise price of such Option, by (ii) the number of share of Eargo common stock (the "Shares")
covered by such Option immediately prior to and upon the Effective Time, with any Options that have a per share exercise price that is greater than or equal to the Merger Consideration being cancelled for no consideration as of the Effective Time.
/s/ Christy La Pierre, Attorney-in-Fact for Afshin Justin Sabet-Peyman
2024-02-20